Yikai Dou

Yikai Dou

Auto-generated profile, based on publicly available information

Yikai Dou

West China School of Medicine: West China Hospital of Sichuan university

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
ZWZuxing Wang
Zuxing Wang
YDYikai Dou
Yikai Dou
XYXiao Yang
Xiao Yang
XGXiaoyun Guo
Xiaoyun Guo
XMXiaohong Ma
Xiaohong Ma
WZWei Zhang
Wei Zhang
Mental disorders among adolescents and young adults (ages 10–24) are a significant public health challenge, contributing to long–term morbidity and substantial societal impact. This study analyzes the prevalence, incidence, and years lived with disability (YLDs) of mental disorders in this age group from 1990–2021, with particular attention to the effects of the COVID–19 pandemic during 2019–2021. Using data from the Global Burden of Disease Study 2021, we estimated the prevalence, incidence, and YLDs, along with age–standardized rates (ASR) and 95% uncertainty intervals (95% UIs) for 2021, stratified by sex and age group. Joinpoint regression was employed to calculate annual percentage change (APC) and average annual percentage change (AAPC), along with their corresponding 95% confidence intervals (CIs). In 2021, the global prevalence of mental disorders among adolescents and young adults was 278.98 million (95% UI: 248.61–312.81), with an ASR of 14,764.94 (95% UI: 2804.87–16,908.09). From 2019–2021, there were significant increases in the prevalence, incidence, and YLDs of mental disorders, especially for depressive and anxiety disorders. High–income regions, including North America, Western Europe, and the Asia Pacific, experienced the highest burdens. Globally, the prevalence of mental disorders was higher in males than females among adolescents aged 10–14, but higher in females among those aged 15–24. Joinpoint regression analysis from 1990–2021 revealed an increased burden in depressive disorders, anxiety disorders, bipolar disorder, eating disorders, autism spectrum disorder, conduct disorder, and idiopathic developmental intellectual disability, while decreases were observed in schizophrenia, ADHD, and other mental disorders. This study highlights the significant impact of COVID–19 on the mental health of adolescents and young adults, revealing disparities by region, age, sex, time period, and cohort. It underscores the need for targeted interventions to address the rising mental health burden in this group.

8 October 2024 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
YYYushun Yan
Yushun Yan
HXHailin Xiang
Hailin Xiang
MWMin Wang
Min Wang
JWJinxue Wei
Jinxue Wei
HFHuanhuan Fan
Huanhuan Fan
XMXiaohong Ma
Xiaohong Ma
Depression is usually accompanied with cognitive impairment and increases risk of incident dementia. However, evidence has been limited on the effect size of depression with cognitive impairment and their synergistic effect on future dementia. To explore this, we examined three large cross-country population-based prospective cohorts. Depressive symptoms were assessed by epidemiologic scale, while cognitive impairment was defined by subjective cognitive tests. Dementia was ascertained by self-reported physician-diagnosed conditions. Cox proportional hazard models were employed to determine the hazard ratio (HR) and 95% confidence interval (95% CI), with adjustments of potential confounding variables. Addictive and multiplicative interactions were calculated to evaluate the synergistic effect. A total of 64,706 participants were included at baseline (mean age: 63.9, female: 55.2%), where 4197 (6.5%) individuals had depressive symptoms only, 28,175 (43.5%) individuals had cognitive impairment only, 11,564 (17.9%) individuals had both, and 20,770 (32.1%) individuals had neither. Compared with the neither group, all the other three groups had higher risks of subsequent dementia (depression only: HR 1.65, 95% CI 1.26–2.17; cognitive impairment only: HR 2.71, 95% CI 2.33–3.14; depression with cognitive impairment: HR 3.51, 95% CI 2.95–4.17). There was insignificant additive (RERI, 0.15, 95% CI −0.45–0.75; AP, 0.042, 95% CI −0.13–0.21; SI, 1.06, 95% CI 0.83–1.37) and multiplicative (0.78, 95% CI 0.58–1.06) interaction between depression and cognitive impairment on subsequent dementia. We found depression with cognitive impairment has higher risks of dementia than either condition alone and no significant synergistic effect exists between these two factors.

27 February 2024 in Cell Proliferation
Verified
Journal Article
Open access
WCWeitong Cui
Weitong Cui
XYXiao Yang
Xiao Yang
YDYikai Dou
Yikai Dou
YDYue Du
Yue Du
XMXiaohong Ma
Xiaohong Ma
YLYunfeng Lin
Yunfeng Lin
Osteoporosis (OP) is a common disease characterized by bone loss and bone tissue microstructure degradation. Drug treatment is a common clinical treatment that aims to increase bone mass and bone density. Tetrahedral DNA nanostructures (TDNs) are three‐dimensional tetrahedral frames formed by folding four single‐stranded DNA molecules, which have good biological safety and can promote bone regeneration. In this study, a mouse model of OP was established by ovariectomy (OVX) and TDN was injected into the tail vein for 8 weeks. We found that ovariectomized mice could simulate some physiological changes in OP. After treatment with TDNs, some of this destruction in mice was significantly improved, including an increase in the bone volume fraction (BV/TV) and bone trabecular number (Tb. N), decrease in bone separation (Tb. SP), reduction in the damage to the mouse cartilage layer, reduction in osteoclast lacunae in bone trabecula, and reduction in the damage to the bone dense part. We also found that the expression of ALP, β‐Catenin, Runx2, Osterix, and bone morphogenetic protein (BMP)2 significantly decreased in OVX mice but increased after TDN treatment. Therefore, this study suggests that TDNs may regulate the Wnt/β‐Catenin and BMP signalling pathways to improve the levels of some specific markers of osteogenic differentiation, such as Runx2, ALP, and Osterix, to promote osteogenesis, thus showing a therapeutic effect on OP mice.

18 December 2024 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
HFHuanhuan Fan
Huanhuan Fan
JLJunhong Li
Junhong Li
YDYikai Dou
Yikai Dou
YYYushun Yan
Yushun Yan
MWMin Wang
Min Wang
XMXiaohong Ma
Xiaohong Ma
Growing evidence links air pollution, a ubiquitous environmental stressor, to a higher risk of developing mental disorders, raising significant public health concerns. Mental disorders represent a significant global public health challenge which can have a profound impact on individual lives. In this study, we used Mendelian randomization (MR) to investigate the causal relationship between ambient air pollution and four common mental disorders. Genome-wide association study (GWAS) data for ambient air pollution and summary-level GWAS data for four representative mental disorders were obtained from open-access database. Inverse variance weighted (IVW) method with multiplicative random-effects model was the main analysis. Sensitivity analyses were conducted to validate the results. Bayesian colocalization analysis was conducted to explore the potential shared genetic causal variants between specific air pollutants and mental disorders. A suggestive association was observed between political matter (PM) 2.5 and anxiety disorders (OR 2.96, 95%CI 1.29–6.81, p = 0.010). Exposure to nitrogen dioxide (NO2) was significantly linked to an elevated risk of schizophrenia (OR 1.95, 95% CI 1.45–2.63, p = 1.13E-05) and showed a nominal association with an increased risk of bipolar disorder (OR 1.43, 95% CI 1.09–1.86, p = 0.009). A suggestive causal association was detected between nitrogen oxides (NOx) and anxiety disorder (OR 2.90, 95%CI 1.21–6.97, p = 0.017). No significant association was detected between exposure to PM2.5-10, PM10 and mental disorders. No significant horizonal pleiotropy and heterogeneity was found. The colocalization analysis revealed robust evidence supporting the colocalization of NO2 with schizophrenia at SNP rs12203592. Our findings support causal associations between exposure to ambient air pollution, particularly PM2.5, NO2, and NOx, and an increased risk of specific mental disorders.

25 November 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SWSixiang Wen
Sixiang Wen
YYYushun Yan
Yushun Yan
JSJunru Shao
Junru Shao
HXHaitao Xie
Haitao Xie
MWMin Wang
Min Wang
XMXiaohong Ma
Xiaohong Ma
Objective Gastrointestinal adverse effects are the most commonly reported adverse effects associated with the use of antidepressants. While existing studies on the gastrointestinal effects of antidepressant medications offer valuable insights, there are still opportunities to enhance the evidence base. Methods We included double-blind randomized controlled trials of major depressive disorder (MDD). Eligible studies must focus on comparing the use of 21 commonly used antidepressants in patients with MDD and reporting data on treatment-emergent gastrointestinal SEs. We selected 196 studies that reported specific numbers of individuals with gastrointestinal adverse effects, involving a total of 57,162 patients. A network and dose‒response meta-analysis was conducted. Results Compared with placebo, 16 antidepressants had higher odds ratios (ORs) for nausea and vomiting, 15 antidepressants had higher ORs for constipation, 8 antidepressants had higher ORs for diarrhoea, 8 antidepressants had higher ORs for anorexia, 12 antidepressants had higher ORs for dry mouth, and 3 antidepressants had higher ORs for dyspepsia. Conclusions Commonly used antidepressants have different gastrointestinal effects. Duloxetine, levomilnacipran, and vilazodone carry a higher risk of inducing nausea and vomiting, whereas trazodone, amitriptyline, agomelatine, and mirtazapine tend to be better tolerated. Amitriptyline, clomipramine, and reboxetine are more prone to induce constipation. Diarrhoea is more commonly associated with vilazodone, fluvoxamine, and sertraline. Amitriptyline, reboxetine, and duloxetine are more likely to cause anorexia. Amitriptyline, reboxetine, and trazodone are related to causing dry mouth. Compared with the placebo, amitriptyline, fluoxetine, and paroxetine were associated with a greater incidence of dyspepsia.

7 May 2024 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YDYikai Dou
Yikai Dou
XYXiao Yang
Xiao Yang
YDYue Du
Yue Du
WCWeitong Cui
Weitong Cui
YLYuling Luo
Yuling Luo
YLYunfeng Lin
Yunfeng Lin